# When the Usual Becomes Unusual: A Closer Look at Mycobacterium marinum Infections

## TL;DR

This paper discusses a case of a rare Mycobacterium marinum infection that was misdiagnosed for months and eventually treated successfully with targeted antibiotics.

## Contribution

The paper highlights the diagnostic challenges and treatment approach for M. marinum infections through a detailed case study.

## Key findings

- M. marinum infections can present as chronic, ulcerated skin lesions that resist standard treatments.
- Combination therapy with minocycline and rifampicin effectively resolved the infection in this case.
- Patient history and histology are crucial for diagnosing M. marinum due to its nonspecific symptoms.

## Abstract

Mycobacterium marinum (M. marinum) is a slow-growing bacterium predominantly found in aquatic environments. While not highly virulent, it can cause skin and soft tissue infections, often misdiagnosed due to their indolent progression.

This paper presents the case of a 42-year-old male data analyst with a chronic, ulcerated lesion on his right middle finger resulting from a minor fish tank injury. Despite multiple interventions, the lesion resisted healing for 10 months. A detailed history raised the suspicion of atypical mycobacterial infection. Despite non-diagnostic initial evaluations, combined antimicrobial therapy with minocycline and rifampicin led to complete lesion healing.

Diagnosing M. marinum infection remains a challenge due to its nonspecific presentation. Key diagnostic criteria include resistance to standard antibiotics, history of exposure to aquatic environments, and potential contamination. While cultures are positive in 70-80% of cases, false negatives can occur, necessitating reliance on patient history and histology. Treatment involves combination antibiotics, with the prognosis generally favorable when treated early.

This case underscores the importance of considering M. marinum in the differential diagnoses of chronic skin lesions and the significance of targeted therapy.